Levels of VE-cadherin increase independently of VEGF in preoperative sera of patients with colorectal cancer

Tumori

Volumn 92, Issue 1, 2006, Pages 67-71

  Sulkowska, Mariola ^a   Famulski, Waldemar ^a   Wincewicz, Andrzej ^a   Moniuszko, Tadeusz ^a   Kȩdra, Bogusław ^a   Koda, Mariusz ^a   Zalewski, Bogdan ^a   Baltaziak, Marek ^a   Sulkowski, Stanislaw ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Angiogenesis; Colorectal cancer; Serum; Ve cadherin; VEGF

Indexed keywords

VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN;

ADULT; ARTICLE; CANCER GRADING; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE PERIOD; PROTEIN BLOOD LEVEL; TUMOR GROWTH;

EID: 33645961882     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160609200111     Document Type: Article

References (27)

1. Altomare DF, Rotelli MT, Memeo V, Martinelli E, Guglielmi A, DeFazio M, D'Elia G, Pentimone A, Colucci M, Semeraro N: Expression of tissue factor and vascular endothelial growth factor in colorectal carcinoma. Tumori, 89: 5-6, 2003.
2. Markovic-Lipkovski J, Brasanac D, Muller GA, Muller CA: Cadherins and integrins in renal cell carcinoma: an immunohistochemical study. Tumori, 87: 173-178, 2001.
3. Caveda L, Martin-Padura I, Navarro P, Breviario F, Corada M, Gulino D, Lampugnani MG, Dejana E: Inhibition of cultured cell growth by vascular endothelial cadherin (cadherin-5/VE-cadherin). J Clin Invest, 98: 886-893, 1996.
4. Tang FY, Nguyen N, Meydani M: Green tea catechins inhibit VEGF-induced angiogenesis in vitro through suppression of VE-cadherin phosphorylation and inactivation of Akt molecule. Int J Cancer, 106: 871-878, 2003.
5. Crosby CV, Fleming PA, Argraves WS, Corada M, Zanetta L, Dejana E, Drake CJ: VE-cadherin is not required for the formation of nascent blood vessels but acts to prevent their disassembly. Blood, 105: 2771-2776, 2005.
6. Corada M, Zanetta L, Orsenigo F, Breviario F, Lampugnani MG, Bernasconi S, Liao F, Hicklin DJ, Bohlen P, Dejana E: A monoclonal antibody to vascular endothelial-cadherin inhibits tumor angiogenesis without side effects on endothelial permeability. Blood, 100: 905-911, 2002.
7. Lin MT, Yen ML, Lin CY, Kuo ML: Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation. Mol Pharmacol, 64: 1029-1036, 2003.
8. Dagnaes-Hansen F, Rasmussen LM, Tilton R, Denner L, Flyvbjerg A: A murine vascular endothelial growth factor antibody inhibits in vivo growth of human Caki-I renal adenocarcinoma. Anticancer Res, 23: 1625-1630, 2003.
9. Kevil CG, Payne DK, Mire E, Alexander JS: Vascular permeability factor/vascular endothelial cell growth factor-mediated permeability occurs through disorganization of endothelial junctional proteins. J Biol Chem, 273: 15099-15103, 1998.
10. Ferrero E, Scabini S, Magni E, Foglieni C, Belloni D, Colombo B, Curnis F, Villa A, Ferrero ME, Corti A: Chromogranin A protects vessels against tumor necrosis factor alpha-induced vascular leakage. FASEB J, 18: 554-556, 2004.
11. Spagnuolo R, Corada M, Orsenigo F, Zanetta L, Deuschle U, Sandy P, Schneider C, Drake CJ, Breviario F, Dejana E: Gas1 is induced by VE-cadherin and vascular endothelial growth factor and inhibits endothelial cell apoptosis. Blood, 103: 3005-3012, 2004.
12. Lampugnani MG, Zanetti A, Corada M, Takahashi T, Balconi G, Breviario F, Orsenigo F, Cattelino A, Kemler R, Daniel TO, Dejana E: Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148. J Cell Biol, 16: 793-804, 2003.
13. Schafer R, Abraham D, Paulus P, Blumer R, Grimm M, Wojta J, Aharinejad S: Impaired VE-cadherin/beta-catenin expression mediates endothelial cell degeneration in dilated cardiomyopathy. Circulation, 108: 1585-1591, 2003.
14. Famulski W, Sulkowska M, Wincewicz A, Kedra B, Pawlak K, Zalewski B, Sulkowski S, Koda M, Baltaziak M: P53 correlates positively with VEGF in preoperative sera of colorectal cancer patients. Neoplasma, 53: 43-48, 2006.
15. Rabascio C, Muratori E, Mancuso P, Calleri A, Raia V, Foutz T, Cinieri S, Veronesi G, Pruneri G, Lampertico P, Iavarone M, Martinelli G, Goldhirsch A, Bertolini F: Assessing tumor angiogenesis: increased circulating VE-cadherin RNA in patients with cancer indicates viability of circulating endothelial cells. Cancer Res, 64: 4373-4377, 2004.
16. Mancuso P, Burlini A, Pruneri G, Goldhirsch A, Martinelli G, Bertolini F: Resting and activated endothelial cells are increased in the peripheral blood of cancer patients. Blood, 97: 3658-3661, 2001.
17. Herren B, Levkau B, Raines EW, Ross R: Cleavage of beta-catenin and plakoglobin and shedding of VE-cadherin during endothelial apoptosis: evidence for a role for caspases and metalloproteinases. Mol Biol Cell, 9: 1589-1601, 1998.
18. Skrzydlewska E, Sulkowski S, Koda M, Zalewski B, Kanczuga-Koda L, Sulkowska M: Lipid peroxidation and antioxidant status in colorectal cancer. World J Gastroenterol, 11: 403-406, 2005.
19. Skrzydlewska E, Sulkowska M, Wincewicz A, Koda M, Sulkowski S: Evaluation of serum cathepsin B and D in relation to clinicopathological staging of colorectal cancer. World J Gastroenterol. 11: 4225-4229, 2005.
20. Zhang HJ, Zhao W, Venkataraman S, Robbins ME, Buettner GR, Kregel KC, Oberley LW: Activation of matrix metalloproteinase-2 by overexpression of manganese superoxide dismutase in human breast cancer MCF-7 cells involves reactive oxygen species. J Biol Chem, 277: 20919-20926, 2002.
21. Spurbeck WW, Ng CY, Strom TS, Vanin EF, Davidoff AM: Enforced expression of tissue inhibitor of matrix metalloproteinase-3 affects functional capillary morphogenesis and inhibits tumor growth in a murine tumor model. Blood, 100: 3361-3368, 2002.
22. Pierce M, Wang C, Stump M, Kamb A: Overexpression of the beta-catenin binding domain of cadherin selectively kills colorectal cancer cells. Int J Cancer, 107: 229-237, 2003.
23. Esser S, Lampugnani MG, Corada M, Dejana E, Risau W: Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. J Cell Sci, 111: 1853-1865, 1998.
24. Shay-Salit A, Shushy M, Wolfovitz E, Yahav H, Breviario F, Dejana E, Resnick N: VEGF receptor 2 and the adherens junction as a mechanical transducer in vascular endothelial cells. Proc Natl Acad Sci USA, 99: 9462-9467, 2002.
25. Hendrix MJ, Seftor EA, Meltzer PS, Gardner LM, Hess AR, Kirschmann DA, Schatteman GC, Seftor RE: Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry. Proc Natl Acad Sci USA, 98: 8018-8023, 2001.
26. Anthony FW, Evans PW, Wheeler T, Wood PJ: Variation in detection of VEGF in maternal serum by immunoassay and the possible influence of binding proteins. Ann Clin Biochem, 34: 276-280, 1997.
27. George ML, Eccles SA, Tutton MG, Abulafi AM, Swift RI: Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging? Clin Cancer Res, 6: 3147-3152, 2000.